Ces radiol. 2017, 71(2):155-159 | DOI: 10.55095/CesRadiol2017/021

Transjugular intrahepatic portasystemic shunt (TIPS) in 2017: basics for interventional radiologistsReview article

Antonín Krajina1, Tomáš Fejfar2
1 Radiologická klinika LF UK a FN, Hradec Králové
2 II. interní gastroenterologická klinika LF UK a FN, Hradec Králové

We can assume that numbers of the TIPS procedures are stable in the last decade. The study which evaluated data from the National Registry in the United States proved decrease of in hospital mortality after TIPS from 12,5% to 10,6% during the same period of time. The predictors of mortality were revealed variceal bleeding, hepatorenal syndrome, abdominal compartment syndrom and signs of advanced liver disease (hepatocellular carcinoma, hepatorenal syndrome, spontaneous bacterial peritonitis, encephalopathy and coagulopathy). TIPS has been performed in Czechia for 25 years with annual frequency of 100 procedures. Introduction of the PTFE covered stentgrafts in TIPS has brought better control of bleeding and ascites in patients with portal hypertension with better survival in selected groups of patients.

Keywords: portal hypertension, TIPS, interventional radiology

Accepted: March 30, 2017; Published: June 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Krajina A, Fejfar T. Transjugular intrahepatic portasystemic shunt (TIPS) in 2017: basics for interventional radiologists. Ces radiol. 2017;71(2):155-159. doi: 10.55095/CesRadiol2017/021.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Franchis R. on behalf of the Baveno VI Faculty. Expanding consensus in portal hypertension. Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol 2015; 63: 743-752. Go to original source... Go to PubMed...
    2. Rössle M, Blanke P, Fritz B, et al. Free hepatic vein pressure is not useful to calculate the portal pressure gradient in cirrhosis: a morphologic and hemodynamic study. J Vasc Interv Radiol 2016; 27: 1130-1137. Go to original source... Go to PubMed...
    3. Fejfar T, Jirkovský V, Šembera Š, et al. Krvácení z varixů - pohled na terapii po Bavenu VI. Gastroent Hepatol 2016; 70(2): 1-8. Go to original source...
    4. Garcia-Pagán JC, Caca K, Bureaou C et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 2010; 362: 2370-2379. Go to original source... Go to PubMed...
    5. Fejfar T, Šafka V, Jirkovský V, et al. Danišův jícnový stent v terapii varikózního krvácení. Gastroent Hepatol 2013; 67: 98-103.
    6. Rees CJ, Nylander LD, Thompson PN, et al. Do gastric and oeophageal varices bleed at different portal pressures and is TIPS an effective treatment? Liver 2000; 20: 253-256. Go to original source... Go to PubMed...
    7. Tesdal IK, Filser T, Weiss C, et al. TIPS: adjunctive embolotherapy of gastroesophageal collateral vessels in the prevention of variceal rebleeding. Radiology 2005; 236, 360-367. Go to original source... Go to PubMed...
    8. Sadd WE, Simon PO jr. Balloon-Occluded Retrograde Transvenous Obliteration of gastric varices. Cardiovasc Intervent Radiol 2014; 37: 299-315. Go to original source... Go to PubMed...
    9. Saad WEA, Wagner C, Lippert A, et al. Protective value of TIPS against the development of hydrothorax/ascites and upper gastrointestinal bleeding after Balloon-Occluded Retrograde Transvenous Obliteration (BRTO). AmerJ Gastroenterol 2013; 108: 1612-1619. Go to original source... Go to PubMed...
    10. Rössle M, Gerbes A. TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update. Gut 2010; 59: 988-1000. Go to original source... Go to PubMed...
    11. Bureau Ch, Thabut D, Oberti F, et al. Transjugular intrahepatic portosystemic shunts with covered stents increase transplant-free survival of patients with cirrhosis and recurrent ascites. Gastroenterol 2017; 152(1): 157-163. Go to original source... Go to PubMed...
    12. Tsochatzis EA, Senzolo M, Germani G, Gatt A, Burroughs AK. Systematic review: portal vein thrombosis in cirrhosis. Aliment Pharmacol Ther 2010; 31: 366-374. Go to original source... Go to PubMed...
    13. Sarin SK, Solano JD, Chawla YK. Consensus on extra-hepatic portal obstruction. Liver International 2006; 26: 512-519. Go to original source... Go to PubMed...
    14. Janoušek L, Adamec M, Oliverius M, et al. Transplantace jater u pacientů s trombózou portální žíly. Rozhl Chir 2011; 90(2): 114-116.
    15. Garcia-Pagán JC, Heydtmann M, Raffa S, et al. TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients. Gastroenterology 2008; 135: 808-815. Go to original source... Go to PubMed...
    16. Routhu M, Safka V, Routhu SK, el al. Observational cohort study of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS). Ann Hepat 2017; 16 (1): 140-148. Go to original source... Go to PubMed...
    17. Pereira K, Carrion AF, Salsamendi J. Endovascular management of refractory hepatic encephalopathy complication of transjugular intrahepatic portosystemic shunt (TIPS): comprehensive review and clinical practice algorithm. Cardiovasc Intervent Radiol 2016; 39: 170-182. Go to original source... Go to PubMed...
    18. Pieper CCh, Jansen Ch, Meyer C, et al. Prospective evaluation of passive expansion of partially dilated transjugular intrahepatic portosystemic shunt stent grafts - a three-dimensional sonography study. J Vasc Interv Radiol 2017; 28: 117-125. Go to original source... Go to PubMed...
    19. Kovács A, Schepke M, Heller J. Short-Term Effects of Transjugular Intrahepatic Shunt on Cardiac Function Assessed by Cardiac MRI: Preliminary Results. Cardiovasc Intervent Radiol 2010; 33: 290-296. Go to original source... Go to PubMed...
    20. Clark TWI, Agarwal R, Haskal ZJ, Stavropoulos SW. The effect of initial shunt outflow position on patency fo transjugular intrahepatic portosystemic shunts. J Vasc Intervent Radiol 2004; 35: 147-152. Go to original source... Go to PubMed...
    21. Bai M, He ChY, Qi XS, et al. Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosytemic shunt. World J Gastroenterol 2014; 20: 774-785. Go to original source... Go to PubMed...
    22. Jirkovsky V, Fejfar T, Safka V, et al. Influence of the secondary deployment of expanded polytetrafluoroethylene - covered stent grafts on maintenance of transjugular intrahepatic portosystemic shunt patency. J Vasc Interv Radiol 2011; 22: 55-60. Go to original source... Go to PubMed...
    23. Trivedi PS, Rochon PJ, Durham JD, et al. National trends and outcomes of transjugular intrahepatic portosystemic shunt creation using the Nationwide Inpatient Sample. J Vasc Interv Radiol 2016; 27: 838-845. Go to original source... Go to PubMed...
    24. Fejfar T,Vaňásek T, Brůha R, et al. Léčba krvácení v důsledku portální Hypertenze při jaterní cirhóze - aktualizace doporučených postupů ČHS ČLS JEP. Gastroent Hepatol 2017; 71: 1-12.

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content